E-Pharm Ltd - Filleted accounts

Registered number

03725304

E-Pharm Ltd

Filleted Accounts

31 March 2025

E-Pharm Ltd
Registered number:		03725304
Balance Sheet
as at 31 March 2025

Notes			2025			2024
£				£
Fixed assets
Intangible assets	3		1			1
Tangible assets	4		15,089			13,834
Investments	5		215,687			7,225
			230,777			21,060

Current assets
Stocks		51,643			45,783
Debtors	6	327,930			450,212
Cash at bank and in hand		1,816,233			1,976,749
		2,195,806			2,472,744

Creditors: amounts falling due within one year	7	(267,195)			(428,329)

Net current assets			1,928,611			2,044,415

Net assets			2,159,388			2,065,475

Capital and reserves
Called up share capital			122			100
Profit and loss account			2,159,266			2,065,375

Shareholders' funds			2,159,388			2,065,475

The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




Mr K Saglani
Director
Approved by the board on 20 November 2025

E-Pharm Ltd
Notes to the Accounts
for the year ended 31 March 2025


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Stocks
	Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.


2	Employees			2025		2024
Number					Number

	Average number of persons employed by the company			6		6


3	Intangible fixed assets					£
	Goodwill:

	Cost
	At 1 April 2024					16,538
	At 31 March 2025					16,538

	Amortisation
	At 1 April 2024					16,537
	At 31 March 2025					16,537

	Net book value
	At 31 March 2025					1
	At 31 March 2024					1

	Goodwill is being written off in equal annual instalments over its estimated economic life of 5 years.


4	Tangible fixed assets
						Plant and machinery etc
£
	Cost
	At 1 April 2024					36,349
	Additions					5,027
	At 31 March 2025					41,376

	Depreciation
	At 1 April 2024					22,515
	Charge for the year					3,772
	At 31 March 2025					26,287

	Net book value
	At 31 March 2025					15,089
	At 31 March 2024					13,834


5	Investments
Investments in
subsidiary			Other
undertakings			investments		Total
£			£		£
	Cost
	At 1 April 2024	7,225		-		7,225
	Additions	-		208,462		208,462

	At 31 March 2025	7,225		208,462		215,687
	The company owns 51% of E-Pharm LLC, incorporated in USA. The net assets of E-Pharm LLC at 31st December 2024 were £152,192.


6	Debtors			2025		2024
£					£

	Trade debtors			292,964		416,776
	Other debtors			34,966		33,436
				327,930		450,212


7	Creditors: amounts falling due within one year			2025		2024
£					£

	Trade creditors			77,294		174,715
	Corporation tax			83,884		124,494
	Other taxes and social security costs			13,792		12,867
	Other creditors			92,225		116,253
				267,195		428,329


8	Other information

	E-Pharm Ltd is a private company limited by shares and incorporated in England. Its registered office is:
	Unit 75 Capital Business Centre
	22 Carlton Road South
	Croydon Surrey
	Surrey
	CR2 0BS